ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2024
[The efficacy and safety of protein A immunoadsorption combined with rituximab treatment for highly sensitized patients undergoing haplo-hematopoietic stem cell transplantation].
Abstract readEnglish Abstract
In one paragraph
Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Plasma exchange combined with anti-B-cell therapy enables comparable outcomes between DSA-positive and DSA-negative aplastic anemia after haplo-HSCT: a propensity-score-matched cohort study.Annals of hematology · 2026Article
- [Chinese expert consensus on quality control, result analysis, and reporting of anti-HLA antibody testing in allogeneic hematopoietic stem cell transplantation (2025)].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
L LiDepartment of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematopoietic Stem Cell Transplantation, Soochow University, Suzhou 215006, China.
W J ZhuDepartment of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematopoietic Stem Cell Transplantation, Soochow University, Suzhou 215006, China.
Q ZhuHematology Department, Soochow Hopes Hematonosis Hospital, Suzhou 215128, China.
S Y ZhouDepartment of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematopoietic Stem Cell Transplantation, Soochow University, Suzhou 215006, China.
C MaHematology Department, Soochow Hopes Hematonosis Hospital, Suzhou 215128, China.
J WangDepartment of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematopoietic Stem Cell Transplantation, Soochow University, Suzhou 215006, China.
X H HuDepartment of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematopoietic Stem Cell Transplantation, Soochow University, Suzhou 215006, China.
Y HanDepartment of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematopoietic Stem Cell Transplantation, Soochow University, Suzhou 215006, China.
Y WangDepartment of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematopoietic Stem Cell Transplantation, Soochow University, Suzhou 215006, China.
X W TangDepartment of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematopoietic Stem Cell Transplantation, Soochow University, Suzhou 215006, China.
X MaDepartment of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematopoietic Stem Cell Transplantation, Soochow University, Suzhou 215006, China.
S N ChenDepartment of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematopoietic Stem Cell Transplantation, Soochow University, Suzhou 215006, China.
H Y QiuDepartment of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematopoietic Stem Cell Transplantation, Soochow University, Suzhou 215006, China.
L Y ChenDepartment of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematopoietic Stem Cell Transplantation, Soochow University, Suzhou 215006, China.
J HeDepartment of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematopoietic Stem Cell Transplantation, Soochow University, Suzhou 215006, China.
D P WuDepartment of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematopoietic Stem Cell Transplantation, Soochow University, Suzhou 215006, China.
X J WuDepartment of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematopoietic Stem Cell Transplantation, Soochow University, Suzhou 215006, China.
Funding
BoXi Clinical Research Program of Soochow University BXLC007Jiangsu Provincial Key Medical CenterNational Key R&D Program of China 2019YFC0840604, 2017YFA0104502National Natural Science Foundation of China 81974001, 82170222, 82171159National Science and Technology Major Project 2017ZX09304021Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) YXZXA2016002Suzhou science and technology plan project SLT201911The Jiangsu Natural Science Foundation BK20211070The Key Disease Program of Suzhou LCZX202101
Abstract
PubMed holds no abstract for this paper.
Indexed as
Hematopoietic Stem Cell TransplantationRituximabStaphylococcal Protein AFemaleHLA AntigensHumansImmunity, HumoralMaleRetrospective StudiesHLA AntigensRituximabStaphylococcal Protein ADesensitization, treatmentHematopoietic stem cell transplantationImmunosorbent techniquesRituximab
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.